Bilateral breast cancer: Analysis of incidence, outcome, survival and disease characteristics

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 131-140

  Kheirelseid, Elrasheid A H ^a   Jumustafa, Hanzali ^a   Miller, Nicola ^a   Curran, Catherine ^a   Sweeney, Karl ^a   Malone, Carmel ^a   McLaughlin, Ray ^a   Newell, John ^a   Kerin, Michael J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Bilateral breast cancer; Breast cancer; Contralateral breast cancer; Synchronous breast cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BILATERAL CANCER; BREAST CANCER; CANCER INCIDENCE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79151473970     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1057-y     Document Type: Article

References (51)

1. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
2. AJ Donovan 1990 Bilateral breast cancer Surg Clin N Am 70 1141 1149 1:STN:280:DyaK3M%2FhvFyjsg%3D%3D 2218824
3. M Michowitz S Noy N Lazebnik D Aladjem 1985 Bilateral breast cancer J Surg Oncol 30 109 112 1:STN:280:DyaL28%2FptVGmsg%3D%3D 10.1002/jso.2930300210 4079423 (Pubitemid 16226334)
4. J Gogas C Markopoulos P Skandalakis H Gogas 1993 Bilateral breast cancer Am Surg 59 733 735 1:STN:280:DyaK2c%2FlslOgtw%3D%3D 8239195 (Pubitemid 23320098)
5. Y Chen W Thompson R Semenciw Y Mao 1999 Epidemiology of contralateral breast cancer Cancer Epidemiol, Biomark Prev 8 855 861 1:STN:280: DC%2BD3c%2FhsVenug%3D%3D (Pubitemid 29508719)
6. MA Chaudary RR Millis EO Hoskins M Halder RD Bulbrook J Cuzick JL Hayward 1984 Bilateral primary breast cancer: a prospective study of disease incidence Br J Surg 71 711 714 1:STN:280:DyaL2M%2FgtFWjsA%3D%3D 10.1002/bjs.1800710924 6478165 (Pubitemid 14066682)
7. DE Heron LT Komarnicky T Hyslop GF Schwartz CM Mansfield 2000 Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease Cancer 88 2739 2750 1:STN:280:DC%2BD3czivFymtw%3D%3D 10.1002/1097-0142(20000615)88:12<2739::AID-CNCR12>3.0.CO;2-J 10870056 (Pubitemid 30417934)
8. LA Newman AA Sahin JE Cunningham ML Bondy NQ Mirza GS Vlastos GJ Whitman H Brown TA Buchholz MH Lee SE Singletary 2001 A case-control study of unilateral and bilateral breast carcinoma patients Cancer 91 1845 1853 1:STN:280:DC%2BD3M3ltVKnsQ%3D%3D 10.1002/1097-0142(20010515)91:10<1845::AID- CNCR1205>3.0.CO;2-Z 11346865 (Pubitemid 32424110)
9. WC Mertens V Hilbert G Makari-Judson 2004 Contralateral breast cancer: factors associated with stage and size at presentation Breast J 10 304 312 10.1111/j.1075-122X.2004.21333.x 15239788 (Pubitemid 38924466)
10. M Hartman K Czene M Reilly J Bergh P Lagiou D Trichopoulos H-O Adami P Hall 2005 Genetic implications of bilateral breast cancer: a population based cohort study Lancet Oncol 6 377 382 10.1016/S1470-2045(05)70174-1 15925815 (Pubitemid 40753743)
11. MM Lee R Heimann C Powers RR Weichselbaum LM Chen 1999 Efficacy of breast conservation therapy in early stage bilateral breast cancer Breast J 5 36 41 10.1046/j.1524-4741.1999.005001036.x 11348254 (Pubitemid 29108807)
12. JJ Jobsen Palen Jvd F Ong JH Meerwaldt 2003 Synchronous, bilateral breast cancer: prognostic value and incidence Breast 12 83 88 1:STN:280: DC%2BD3srnvVyksQ%3D%3D 10.1016/S0960-9776(02)00278-3 14659335 (Pubitemid 36546431)
13. TM Tuttle S Jarosek EB Habermann A Arrington A Abraham TJ Morris BA Virnig 2009 Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ J Clin Oncol 27 1362 1367 10.1200/JCO.2008.20.1681 19224844
14. LC Hartmann DJ Schaid JE Woods TP Crotty JL Mayers PG Arnold PM Petty TA Sellers JL Johnson SK McDonnell MH Frost RB Jenkins 1999 Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer N Engl J Med 340 77 84 1:STN:280:DyaK1M%2FptFSqsw%3D%3D 10.1056/NEJM199901143400201 9887158 (Pubitemid 29054841)
15. G Quan SJ Pommier RF Pommier 2008 Incidence and outcomes of contralateral breast cancers Am J Surg 195 645 650 10.1016/j.amjsurg.2008.01.007 18424281 (Pubitemid 351522201)
16. SG Lee SG Orel IJ Woo E Cruz-Jove ME Putt LJ Solin BJ Czerniecki MD Schnall 2003 MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results Radiology 226 773 778 10.1148/radiol.2263020041 12601182 (Pubitemid 36259154)
17. C Boetes J Veltman 2005 Screening women at increased risk with MRI Cancer Imaging 23 S10 S15 10.1102/1470-7330.2005.0040
18. AR Carmichael S Bendall L Lockerbie R Prescott T Bates 2002 The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours Eur J Surg Oncol 28 388 391 1:STN:280:DC%2BD38zlslShuw%3D%3D 10.1053/ejso.2002.1266 12099647
19. HO Adami R Bergstrom J Hansen 1985 Age at first primary as a determinant of the incidence of bilateral breast cancer: cumulative and relative risks in a population-based case-control study Cancer 55 643 647 1:STN:280: DyaL2M%2FnsVSmug%3D%3D 10.1002/1097-0142(19850201)55:3<643::AID- CNCR2820550328>3.0.CO;2-L 3965112 (Pubitemid 15156037)
20. H Brenner B Engelsmann C Stegmaier H Ziegler 1993 Clinical epidemiology of bilateral breast cancer Cancer 72 3629 3635 1:STN:280:DyaK2c%2FntlyjtA%3D%3D 10.1002/1097-0142(19931215)72:12<3629::AID-CNCR2820721213>3.0.CO;2-T 8252478 (Pubitemid 24000597)
21. HF Rauschecker W Sauerbrei W Gatzemeier R Sauer A Schauer C Schmoor M Schumacher 1998 Eight-year results of a prospective non-randomized study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG) Eur J Cancer 34 315 323 1:STN:280:DyaK1czgsVeqtQ%3D%3D 10.1016/S0959-8049(97)10035-1 9640215 (Pubitemid 28183827)
22. I Abdalla RA Thisted R Heinmann 2000 The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy Cancer 6 266 272 1:STN:280:DC%2BD3cvoslyruw%3D%3D
23. RS Samant IA Olivotto ISH Jakson D Mates 2001 Diagnosis of metachronous contralateral breast cancer Breast J 7 405 410 1:STN:280:DC%2BD387hvVajuw%3D%3D 10.1046/j.1524-4741.2001.07605.x 11843852 (Pubitemid 34024463)
24. CK Gajalakshmi V Shanta M Hakama 1999 Survival from contralateral breast cancer Breast Cancer Res Treat 58 115 122 1:STN:280:DC%2BD3c7jslensg%3D%3D 10.1023/A:1006361608241 10674875 (Pubitemid 30032482)
25. T Irvine DS Allen C Gillett H Hamed IS Fentiman 2009 Prognosis of synchronous bilateral breast cancer Br J Surg 96 376 380 1:STN:280: DC%2BD1M3hsVyjug%3D%3D 10.1002/bjs.6553 19283743
26. ML Lesser PP Rosen DW Kinne 1982 Multicentricity and bilaterality in invasive breast carcinoma Surgery 91 234 240 1:STN:280:DyaL387ivFKmsQ%3D%3D 6277027
27. A de la Rochefordiere B Asselain S Scholl F Campana L Ucla JR Vilcoq JC Durand P Pouillart A Fourquet 1994 Simultaneous bilateral breast carcinoma: a retrospective review of 149 cases Int J Radiat Oncol Biol Phys 30 35 41 (Pubitemid 24291111)
28. D Coradini S Oriana L Mariani R Miceli G Bresciani E Marubini G Di Fronzo 1998 Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour? Eur J Cancer 34 825 830 1:STN:280:DyaK1M%2FhsVChtQ%3D%3D 10.1016/S0959-8049(97)10121-6 9797693 (Pubitemid 28248492)
29. CD Lehman C Gatsonis CK Kuhl RE Hendrick ED Pisano L Hanna S Peacock SF Smazal DD Maki TB Julian ER DePeri DA Bluemke MD Schnall 2007 MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer N Engl J Med 356 1295 1303 1:CAS:528:DC%2BD2sXjsFGht70%3D 10.1056/NEJMoa065447 17392300 (Pubitemid 46513295)
30. M Kriege CT Brekelmans C Boetes PE Besnard HM Zonderland IM Obdeijn RA Manoliu T Kok H Peterse MM Tilanus-Linthorst SH Muller S Meijer JC Oosterwijk LV Beex RA Tollenaar HJ de Koning EJ Rutgers JG Klijn 2004 Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 427 437 1:CAS:528:DC%2BD2cXmtFalu7o%3D 10.1056/NEJMoa031759 15282350 (Pubitemid 38988592)
31. P Viehweg K Rotter M Laniado D Lampe J Buchmann H Kölbl S Heywang-Köbrunner 2004 MR imaging of the contralateral breast in patients after breast-conserving therapy Eur Radiol 14 402 408 10.1007/s00330-003-2086-2 14531008 (Pubitemid 38324914)
32. CD Lehman JD Blume D Thickman DA Bluemke E Pisano C Kuhl TB Julian N Hylton P Weatherall M O'loughlin SJ Schnitt C Gatsonis MD Schnall 2005 Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial J Surg Oncol 92 9 15 10.1002/jso.20350 16180217 (Pubitemid 41416422)
33. SG Moore PJ Shenoy L Fanucchi JW Tumeh CR Flowers 2009 Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population BMC Health Serv Res 9 9 10.1186/1472-6963-9-9 19144138
34. L Bertelsen L Bernstein JH Olsen L Mellemkjaer RW Haile CF Lynch KE Malone H Anton-Culver J Christensen B Langholz DC Thomas CB Begg M Capanu B Ejlertsen M Stovall JD Boice Jr S Re Women's Environment CaRESCG JL Bernstein 2008 Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study J Natl Cancer Inst 100 32 40 1:CAS:528:DC%2BD1cXlslOqu7o%3D 10.1093/jnci/djm267 18159070 (Pubitemid 351767339)
35. VG Vogel JP Costantino DL Wickerham WM Cronin RS Cecchini JN Atkins TB Bevers L Fehrenbacher ER Pajon Jr JL Wade III A Robidoux RG Margolese J James SM Lippman CD Runowicz PA Ganz SE Reis W McCaskill-Stevens LG Ford VC Jordan N Wolmark 2006 Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial JAMA 295 2727 2741 1:CAS:528: DC%2BD28XmtFOltLc%3D 10.1001/jama.295.23.joc60074 16754727 (Pubitemid 43920726)
36. Early Breast Cancer Trialists' Collaborative Group 1998 Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 351 1451 1467 10.1016/S0140-6736(97)11423-4 (Pubitemid 28227036)
37. I Bedrosian CY Hu GJ Chang 2010 Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients J Natl Cancer Inst 102 6 401 409 10.1093/jnci/djq018 20185801
38. EA Peralta JD Ellenhorn LD Wagman A Dagis JS Andersen DZ Chu 2000 Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer Am J Surg 180 439 445 1:STN:280:DC%2BD3M7lvVWqsQ%3D%3D 10.1016/S0002-9610(00)00505-5 11182394 (Pubitemid 32166835)
39. SM Zion JM Slezak TA Sellers JE Woods PG Arnold PM Petty JH Donohue MH Frost DJ Schaid LC Hartmann 2003 Reoperations after prophylactic mastectomy with or without implant reconstruction Cancer 98 2152 2160 10.1002/cncr.11757 14601084 (Pubitemid 37392418)
40. MH Frost JM Slezak NV Tran CI Williams JL Johnson JE Woods PM Petty JH Donohue CS Grant JA Sloan TA Sellers LC Hartmann 2005 Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance J Clin Oncol 23 7849 7856 10.1200/JCO.2005.09.233 16204003 (Pubitemid 46657383)
41. SV Gollamudi RS Gelman G Peiro LJ Schneider SJ Schnitt A Recht BJ Silver JR Harris JL Connolly 1997 Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma Cancer 79 1362 1369 1:STN:280:DyaK2s3js1ClsQ%3D%3D 10.1002/(SICI)1097-0142(19970401)79:7<1362::AID-CNCR14>3.0.CO;2-Y 9083159 (Pubitemid 27143244)
42. C Yamauchi M Mitsumori Y Nagata M Kokubo T Inamoto K Mise H Kodama M Hiraoka 2005 Bilateral breast-conserving therapy for bilateral breast cancer: results and consideration of radiation technique Breast Cancer 12 135 139 10.2325/jbcs.12.135 15858445
43. JL Bernstein WD Thompson N Risch TR Holford 1992 Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer Am J Epidemiol 136 925 936 1:STN:280: DyaK3s%2FovFehsw%3D%3D 1456269
44. CK Gajalakshmi V Shanta M Hakama 1998 Risk factors for contralateral breast cancer in Chennai (Madras), India Int J Epidemiol 27 743 750 1:STN:280:DyaK1M%2FltlClsQ%3D%3D 10.1093/ije/27.5.743 9839728 (Pubitemid 28504959)
45. B Fisher S Anderson J Bryant RG Margolese M Deutsch ER Fisher JH Jeong N Wolmark 2002 Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 1233 1241 10.1056/NEJMoa022152 12393820 (Pubitemid 35176242)
46. JD Boice Jr EB Harvey M Blettner M Stovall JT Flannery 1992 Cancer in the contralateral breast after radiotherapy for breast cancer N Engl J Med 326 781 785 10.1056/NEJM199203193261201 1538720
47. HH Storm M Andersson JD Boice Jr M Blettner M Stovall HT Mouridsen P Dombernowsky C Rose A Jacobsen M Pedersen 1992 Adjuvant radiotherapy and risk of contralateral breast cancer J Natl Cancer Inst 84 1245 1250 1:STN:280:DyaK38zkvFCmtw%3D%3D 10.1093/jnci/84.16.1245 1640483
48. X Gao SG Fisher B Emami 2003 Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study Int J Radiat Oncol Biol Phys 56 1038 1045 10.1016/S0360-3016(03)00203-7 12829139 (Pubitemid 36794035)
49. H Takahashi K Watanabe M Takahashi K Taguchi F Sasaki S Todo 2005 The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer Breast Cancer 12 196 202 10.2325/jbcs.12.196 16110289
50. HM Verkooijen V Chatelain G Fioretta G Vlastos E Rapiti AP Sappino C Bouchardy PO Chappuis 2007 Survival after bilateral breast cancer: results from a population-based study Breast Cancer Res Treat 105 347 357 10.1007/s10549-006-9455-x 17186359 (Pubitemid 47596444)
51. JN Mhuircheartaigh C Curran E Hennessy MJ Kerin 2008 Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma Br J Surg 95 827 833 10.1002/bjs.6042 18498127